Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Haplogen GmbH

Headquarters: Vienna, Austria
Year Founded: 2010
Status: Archived

Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.

BioCentury | Sep 28, 2017
Preclinical News

Researchers report first Haplobank data

BioCentury | Jan 18, 2017
Distillery Therapeutics

Infectious disease

BioCentury | Jul 13, 2015
Company News

Cyclenium Pharma, Haplogen deal

BioCentury | Sep 26, 2013
Distillery Techniques

Technology: Disease models

BioCentury | Sep 26, 2013
Tools & Techniques

Trapping human genes

BioCentury | Dec 17, 2012
Emerging Company Profile

Haplogen: Mining for host factors

Haplogen screening haploid cells for new host-factor targets to block infections
BioCentury | Nov 19, 2012
Company News

Evotec, Haplogen deal

BioCentury | Nov 19, 2012
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Sep 8, 2011
Targets & Mechanisms

Niemann-Pick(ing) on Ebola

Items per page:
1 - 10 of 10
Help Center
Username
Request a Demo
Request Training
Ask a Question